Precigen (PGEN) Long-Term Investments (2012 - 2026)
Precigen's (PGEN) quarterly Long-Term Investments came in at $489000.0 in Q1 2026, down 34.8% year-on-year from $750000.0 in Q1 2025, and down 80.53% on a QoQ basis from $2.5 million in Q4 2025.
Precigen (PGEN) Long-Term Investments (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Long-Term Investments data on file, last reported at $489000.0 in Q1 2026.
- On a quarterly basis, Long-Term Investments fell 34.8% year-over-year to $489000.0 in Q1 2026; TTM through Mar 2026 was $489000.0, a 34.8% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, changed N/A from the prior year.
- Long-Term Investments for Q1 2026 stood at $489000.0, down from $2.5 million in the prior quarter.
- Over the last five years, Long-Term Investments for PGEN reached as high as $29.9 million in Q1 2022 and fell as low as $489000.0 in Q1 2026.
- Historically, Long-Term Investments has averaged $7.5 million across 4 years, with a median of $5.3 million in 2023.
- Across the five-year window, Long-Term Investments tumbled 86.07% in 2022 and tumbled 34.8% in 2026, its largest moves.
- Year by year, Long-Term Investments stood at $11.9 million in 2022, then slumped by 55.62% to $5.3 million in 2023, then slumped by 52.36% to $2.5 million in 2025, then tumbled by 80.53% to $489000.0 in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $489000.0 in Q1 2026, $2.5 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 489,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489,000.00 |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Mar 31, 2025 | 750,000.00 |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 7.13 Mn |
| Mar 31, 2023 | 7.46 Mn |
| Jun 30, 2022 | 11.88 Mn |
| Mar 31, 2022 | 29.91 Mn |
| Dec 31, 2021 | 48.56 Mn |
| Sep 30, 2021 | 66.93 Mn |
| Jun 30, 2021 | 85.27 Mn |
| Mar 31, 2021 | 103.61 Mn |
| Sep 30, 2020 | 337,000.00 |
| Jun 30, 2020 | 859,000.00 |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.46 Mn |
| Sep 30, 2019 | 6.52 Mn |
| Jun 30, 2019 | 18.09 Mn |
| Mar 31, 2019 | 1.60 Mn |